RT-qPCR results showed that SOD1 exhibited consistent expression with HSP90AA1 and HSPA8, while SREBF2 and GTAT2 were highly expressed in non-malignant ovarian tumor tissues and significantly decreased in high-grade serous ovarian cancer samples. This evidence concerns the gene SOD1 and ovarian neoplasm.